Authors
Loading...
Retrospective analysis reveals better survival and treatment initiation rates for Burkitt lymphoma patients in academic cancer programs, suggesting systemic therapy benefits.
Ascencio et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: